| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |